Aktuellt
SENASTE
FluoGuide announced publication of preclinical studies of its new candidate, FG002, which is in development for fluorescence-guided surgery in colorectal cancer. The study shows that FG002 is highly potent and performs well in terms of several important metrics, as well as demonstrating that FlouGuide is more than just a one-product company. We view this as a positive, albeit early, further step forward.
LÄS MER
